Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Capital Hilton

Oct 28, 2024 7:00 AM - Oct 30, 2024 7:00 PM

1001 16th Street NW, , Washington, DC 20036-5794 , USA

DIA/FDA Oligonucleotide-Based Therapeutics Conference

Call for Posters and Roundtables Ends

DAYS

HOURS

MINUTES

SECONDS

Session 2 Track 1: Extra-Hepatic Delivery – Clinical Experience: Emerging

Session Chair(s)

Xing  Jing, PhD, MBA

Xing Jing, PhD, MBA

Reviewer

FDA, United States

Arthur A. Levin, PhD

Arthur A. Levin, PhD

Distinguished Scientist

Avidity Biosciences, United States

Track 1: Extra-Hepatic Delivery – Clinical Experience: Emerging

Speaker(s)

Representative Invited

Pulmonary Delivery Platform and Clinical Programs

Representative Invited

Arrowhead Pharmaceuticals, United States

Thomas  Thum

Cardiac Delivery of Oligonucleotides

Thomas Thum

Cardior Pharmaceuticlas GmbH, Germany

CSO

Allison  August

Delivery of siRNA to Placenta for Treatment of Preeclampsia

Allison August

Comanche Biopharma, United States

Chief Medical Officer

Steve  Hughes, MD, MBA

Delivery of Oligonucleotides to Muscle in Patients

Steve Hughes, MD, MBA

Avidity Biosciences, United States

Chief Medical Officer

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.